<DOC>
	<DOC>NCT01228526</DOC>
	<brief_summary>To evaluate the effectiveness of PriMatrix in the treatment of DFUs in subjects without significantly compromised arterial circulation.</brief_summary>
	<brief_title>A Multicenter, Prospective, Observational Study With PriMatrix for the Treatment of Neuropathic Diabetic Foot Ulcers</brief_title>
	<detailed_description />
	<mesh_term>Foot Ulcer</mesh_term>
	<mesh_term>Diabetic Foot</mesh_term>
	<criteria>Type I or Type II diabetes with investigatorconfirmed reasonable metabolic control Peripheral neuropathy A full thickness diabetic plantar foot ulcer of at least 1 cm2 but not exceeding 10 cm2 in area An ulcer which has been in existence for a minimum of 30 days, prior to the day of screening Suspected or confirmed signs/symptoms of wound infection Wounds with exposed bone or tendon Hypersensitivity to bovine collagen</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2016</verification_date>
</DOC>